Abstract
The tolerogenic phenotype of human dendritic cells is characterized by high cell surface expression of the inhibitory receptor ILT3. ILT3 signals both intracellularly inhibiting tyrosine phosphorylation, NF-κB and MAPK p38 activity, transcription of certain co-stimulatory molecules, secretion of cytokines and chemokines, and extracellularly into the T cells with which the dendritic cells interact. Both ILT3high tolerogenic dendritic cells and soluble ILT3 induce CD4 Th anergy and differentiation of antigen specific CD8 T suppressor cells. Recombinant ILT3-Fc protein has important immunotherapeutic potential acting directly on activated T cells and promoting the induction of immunological tolerance.
Original language | English (US) |
---|---|
Pages (from-to) | 119-132 |
Number of pages | 14 |
Journal | International Reviews of Immunology |
Volume | 29 |
Issue number | 2 |
DOIs | |
State | Published - Mar 2010 |
Externally published | Yes |
Keywords
- Dendritic cells
- ILT receptors
- T suppressor cells
- Tolerance
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology